Sign up Log-In

Home Page Strains Strain Detail

Back to Strains Library

Critical Mass

Overview:

Critical Mass is an earthy, yet citrusy indica. Composed of Skunk #1 and Afghani, Critical Mass is known for its massive, leafy branches. Since it is mostly leaves, the branches can begin to snap before they flower at six to eight weeks. However, beware of mold! Critical Mass is notorious for developing it. Since it is a strong indica, it is a good bedtime strain. It treats pain effectively due to the intense body buzz, as well as insomnia and anxiety. For anyone struggling with Post-Traumatic Stress Disorder symptoms, Critical Mass may be for you.

Strain Attributes:

Effects

Euphoric

Happy

Relaxed

Sleepy

Uplifted

Euphoric

Happy

Relaxed

Sleepy

Uplifted

Medical Uses

Depression

Insomnia

Muscle Spasms

Pain

Stress

Depression

Insomnia

Muscle Spasms

Pain

Stress

Negatives

Anxious

Dizzy

Dry Eyes

Dry Mouth

Paranoid

Anxious

Dizzy

Dry Eyes

Dry Mouth

Paranoid

Rate this Strain!

SPONSORS

FROM OUR BLOG

Cannabis Events Near You Page Now Live With Festivals and Conferences

The all new Cannabis.net "EVENTS" page in now live. You can now check for cannabis conferences and festivals coming up near you. We didn't stop there either.

Cannabis Can Treat Some of Autism's Core Symptoms and Marijuana Extracts May be the Key Says New Medical Study

For many years now, cannabis has shown to be promising for the management of autism. In a brand-new study out of Brazil, researchers shared their findings when they studied the impact of plant-based cannabis extracts among 20 participants who have been diagnosed with autism spectrum disorder (ASD). The participants were asked to take the marijuana extracts for a minimum of 6 months orally; these formulations contained either mostly THC or CBD though these were individually formulated.

Study Shows Combination of CBD and Terpenes Can Fight COVID-19, But Where Does That Leave THC?

According to researchers, the CBD treatment alone inhibited an average of 75 percent of cytokines, while terpenes alone inhibited around 80 percent. Meanwhile, NT-VRL inhibited around 90 percent of cytokines and Dexamethasone inhibited roughly 30 percent. The two firms called the preliminary results ‘highly positive,’ and said that the compound demonstrates the significant anti-inflammatory benefits of terpenes.